KLA  stock jumps 8% on Friday rebound as chip gear rallies; dividend set for March

KLA stock jumps 8% on Friday rebound as chip gear rallies; dividend set for March

New York, Feb 6, 2026, 19:14 EST — After-hours

  • KLA shares jumped 8.4% at Friday’s close, clawing back some ground after a volatile week.
  • Chip-equipment stocks caught a lift as risk appetite returned to the market.
  • U.S. jobs and inflation figures coming up next week will put rate-sensitive tech stocks to the test.

KLA Corp finished Friday up 8.4%, closing at $1,442.95. The stock bounced around, trading between $1,340.02 and $1,449.00 over the session.

KLA shares climbed, landing it near the top of chip equipment gainers as investors picked up tech names linked to data-center demand—this after the broader market logged three losing sessions in a row. 1

KLA’s customers lock in capital spending plans well ahead of time, making the stock a kind of stand-in for bets on the next phase of artificial-intelligence infrastructure. The company’s gear — process-control tools, inspection systems, metrology hardware — helps chipmakers catch defects and improve yields. Orders, as a result, usually arrive on the heels of new fabrication builds.

Amazon’s outlook for a big jump in AI spending changed the mood on Friday, though shares slipped. “This trade has been volatile,” said Ross Mayfield, investment strategy analyst at Baird, noting buyers moved back in after dips. 1

KLA’s board, according to a U.S. securities filing Thursday, approved a quarterly cash dividend of $1.90 per share. That payout is scheduled for March 3, with the cutoff for shareholders of record set at Feb. 17. 2

Other names in the sector saw steep gains Friday. Applied Materials popped 6.1%, while Lam Research jumped 8.3%, market data showed. 3

But the rally unfolded while the AI sector was whipsawing, investors wrestling with just how fast all that spending will translate into earnings—and whether the upbeat narrative is already baked into valuations. Equipment names can take a hit if large buyers start sounding less eager or if there’s even a whisper of tool shipments getting pushed back.

Next week could be a real test for the macro picture. The January U.S. jobs report, postponed by the shutdown, is now slated for Feb. 11. Then, two days later, the January CPI figures drop at 8:30 a.m. ET on Feb. 13. 4

With KLA, eyes turn to whether Friday’s action carries over when markets open Monday, and if the upcoming Feb. 17 dividend record date manages to pull in extra buyers before then.

Stock Market Today

Citigroup stock price jumps as consent-order exit comes back into focus

Citigroup stock price jumps as consent-order exit comes back into focus

7 February 2026
Citigroup shares jumped 6% to $122.69 Friday before holding steady after hours, as executives grew more confident about resolving longstanding regulatory consent orders this year, sources said. The Dow closed above 50,000 for the first time, gaining 2.47%. Citi also announced it will match the U.S. government’s $1,000 “Trump Accounts” contribution for eligible employees’ families.
MercadoLibre stock slides into the weekend as the market rallies — what MELI investors watch next

MercadoLibre stock slides into the weekend as the market rallies — what MELI investors watch next

7 February 2026
MercadoLibre shares fell 3.18% to $1,970.15 Friday, bucking a broad U.S. market rally. The stock has dropped about 6% over four sessions as traders await fourth-quarter results, provisionally set for Feb. 24. Analysts expect earnings per share of $11.66, down 7.5% from last year, with revenue up 40% to $8.49 billion. Margins, currency swings, and credit trends in Brazil, Mexico, and Argentina remain in focus.
Booking (BKNG) stock steadies after hours as AI worries split analysts
Previous Story

Booking (BKNG) stock steadies after hours as AI worries split analysts

Boston Scientific stock price slips again after earnings shock as BSX investors eye heart-rhythm sales
Next Story

Boston Scientific stock price slips again after earnings shock as BSX investors eye heart-rhythm sales

Go toTop